gvtcx

Human Derived Blood Products

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£69,978,867
Statuscomplete
Category (CPV) 33141000 +1 more
RegionWales
Deadline22 May 2024
Procedureopen
OCIDocds-h6vhtk-045307

Awards (7)

This procurement was awarded to 7 suppliers. Values shown are per-award; the notice total is £69,978,867.

SupplierValueDateStatus
Bio Products Laboratory Ltd shared · · ·
CSL BEHRING UK LIMITED shared · · active
GRIFOLS UK LIMITED shared · · active
LFB BIOPHARMACEUTICALS LTD shared · · ·
OCTAPHARMA LIMITED shared · · active
Pharming Group shared · · active
TAKEDA U K LTD shared · · ·

description

NHS Wales Shared Services Partnership Procurement Services (NWSSP ProcS), hosted by Velindre NHS Trust, invites tenders on behalf of NHS Wales to appoint suitably qualified supplier(s) for Human Derived Blood Products.

This procurement will involve the establishment of a Framework Agreement. The duration of this contract will be four years.

Please refer to the ITT documentation found at https://etenderwales.bravosolution.co.uk/web/login.shtml

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
17 Apr 2024 Contract notice (F02) Earlier regulations 012514-2024
28 Aug 2024 Contract award notice (F03) Earlier regulations 027425-2024

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.